A clinical pharmacology study of fixed vs. free combination of inhaled beclometasone dipropionate and formoterol fumarate dry powder inhalers in asthmatic adolescents

Br J Clin Pharmacol. 2014 Nov;78(5):1169-71. doi: 10.1111/bcp.12424.

Authors

Bo L Chawes¹, Mirco Govoni, Annalisa Piccinno, Eskil Kreiner-Møller, Nadja H Vissing, Li Mortensen, Erik Nilsson, Amalie Bisgaard, Maja Deleuran, Nanna Skytt, Nasim Samandari, Daniela Acerbi, Hans Bisgaard

Affiliation

¹ Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen & Danish Pediatric Asthma Center, Copenhagen University Hospital, Gentofte, Denmark.

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Administration, Inhalation
Adolescent
Anti-Asthmatic Agents / administration & dosage*
Anti-Asthmatic Agents / adverse effects
Anti-Asthmatic Agents / pharmacokinetics
Anti-Asthmatic Agents / therapeutic use
Asthma / blood
Asthma / drug therapy*
Beclomethasone / administration & dosage*
Beclomethasone / adverse effects
Beclomethasone / pharmacokinetics
Beclomethasone / therapeutic use
Biological Availability
Cross-Over Studies
Drug Combinations
Drug Therapy, Combination
Dry Powder Inhalers
Ethanolamines / administration & dosage*
Ethanolamines / adverse effects
Ethanolamines / pharmacokinetics
Ethanolamines / therapeutic use
Female
Formoterol Fumarate
Humans
Male
Patient Compliance

Substances

Anti-Asthmatic Agents
Drug Combinations
Ethanolamines
Beclomethasone
Formoterol Fumarate

Associated data

ClinicalTrials.gov/NCT01191424